Background & Purpose: To provide guidance regarding the preferred Voxel Based
Introduction:
The hippocampus is a key brain area in Alzheimer's disease (AD) as it is the site of highest and earliest neuropathological and structural alterations, including neurofibrillary tangles, neuronal loss and atrophy on brain imaging. 1, 2, 3 Furthermore, hippocampal atrophy is a consistent feature in amnestic Mild Cognitive Impairment (aMCI), a clinical entity that best represents the predementia stage of AD. 4 Hippocampal atrophy has been shown to be associated with increased risk of developing clinical probable AD in aMCI, 1, 3, 5 and is considered a supportive feature for the clinical diagnosis of AD. Over and above detection of hippocampal atrophy for clinical purposes, hippocampal size measurement is also used to assess its relationships with other AD-related brain or cognitive changes in order to better understand the causes and consequences of this early pathologic process. 6, 7 Although other automatic or semi-automatic methods of hippocampal segmentation have been developed over the past decade, 8, 9 ,10 the two main methods currently used to assess hippocampal atrophy are i) individual manual Region of Interest (ROI-i) and ii) Voxel Based Morphometry (VBM) using Statistical Parametric Mapping (SPM). The latter is widely used as an automatic voxel-based method, whereas the former more labour-intensive yet is considered as the gold-standard. The validity of VBM to assess hippocampal atrophy has been debated, due to the spatial normalization and smoothing steps required for voxel-based group analyses that may compromise the measure of atrophy in small and complex structures such as the hippocampus. A few studies have been conducted to compare the sensitivity of VBM versus the ROI-i approaches for the detection of hippocampal atrophy in AD, 11, 12 and in fact the findings overall argue for the validity of VBM, showing at least comparable sensitivity for both approaches.
However, quantitative measures for hippocampal volume using VBM can be extracted in different ways and from different kinds of VBM-derived images. Thus hippocampal volume 4 can be extracted either directly from gray matter (GM) density maps or using VBM-toolbox, from two different types of modulated GM volume datasets (see below). In addition, quantitative measures can then be extracted either by superimposing a ROI of the hippocampus traced on a customized template onto VBM-derived images, or using the peak value of hippocampal atrophy identified through a preliminary whole brain analysis. 13, 14 Thus our objective with the present study is to give further insight onto the different 
Materials and methods

Participants
Subjects' characteristics are summarized in Table 1 . A total of 41 right-handed subjects were studied, including 23 patients with aMCI and 18 healthy elderly. aMCI patients were prospectively recruited through a memory clinic, which they all attended for a complaint of memory impairment. At the time of the study, none of the patients was or had been treated with specific medication such as anti-acetylcholinesterase agents. were still classified as aMCI, and one was unclassified because of incomplete follow-up information. The overall rate of conversion in aMCI patients was thus 23% per year. Finally, all subjects included in this study gave informed consent for the protocol, which was approved by the Regional Ethics Committee.
Neuroimaging procedure
For each subject, a high-resolution T1-weighted volume MRI scan was obtained, which consisted of a set of 128 adjacent axial cuts parallel to the AC-PC line and with slice thickness 1.5mm and pixel size 0.94 x 0.94mm (TR = 10.3 ms; TE = 2.1 ms; FOV = 24x18 cm; matrix = 256x192). All the MRI data sets were acquired on the same scanner (1.5 T Sigma Advantage echospeed; General Electric).
Briefly, as mentioned in the introduction, we used individual ROI measurements and three types of VBM-derived data (unmodulated, m_modulated and m0_modulated), and two different statistical approaches to extract quantitative measures of hippocampal volumetry from these VBM-derived datasets, namely from an hippocampal ROI delineated on a customized MRI template -referred to as the ROI-template (ROI-t) method, or from the peak voxel with most significant hippocampal atrophy in a preliminary whole-brain VBM analysis -referred to 6 as the Hip-peak method. These six sets of values were then first entered into six independent ANOVAs, and AUC from ROC curves were also computed, to compare their accuracy for detecting hippocampal atrophy in aMCI to that of the ROI-i gold-standard method. Second, the same six sets of values were entered in correlation analyses with the ROI-i-derived hippocampal volumes in order to identify the SPM-derived method best correlated to the ROI-i method.
Individual ROI approach: Using MRIcro software, 16 right and left hippocampal anatomic boundaries were drawn from anterior to posterior on native MRI sections displayed in coronal orientation. The ROI-i were delineated blinded to diagnostic group by the same experienced observer (KM) using similar tracing rules as those used in a previously published study. 14 The ROI-i were traced twice by the same observer in a subsample of 14 randomly-selected participants about 3 months apart and Intraclass Correlation Coefficients (ICC) were computed to assess the reliability of the tracings. The ICC for an absolute agreement between measures (same rater for all subjects) was 0.9975 and 0.9941 for the right and left hippocampus respectively.
VBM approach: MRI data were preprocessed using the VBM5 tool implemented in SPM5.
This is an improved version of the standard VBM procedure described in detail elsewhere 17 and already used in previous studies. 18, 15 Briefly, it includes the standard bias correction, spatial normalization onto the MNI template, and segmentation steps, but instead of each step being performed serially as previously, they are combined / alternated in VBM5, allowing more accurate estimations. Computing our original MRI data sets through the VBM5 process, we obtained spatially normalized unmodulated GM density images as well as the two different kinds of modulated images. Modulation allows compensating for the effect of spatial normalization that causes volume changes due to both affine transformation (global scaling) and non-linear warping (local volume change With respect to the Hip-peak method, the m_modulated, m0_modulated and unmodulated MRI datasets were smoothed (FWHM=12), masked and entered in SPM5
analyses comparing controls and aMCI patients (using the "Two sample t-test" routine and introducing TIV as a covariate for the m_modulated data analysis). In sum, seven sets of individual right and left hippocampal measures were obtained; the ROI-i measures were extracted from the native space MRI data, the ROI-t values were extracted from the m_modulated, m0_modulated and unmodulated normalized GM partitions;
and the Hip-peak values were extracted from the preliminary SPM group comparison analyses onto normalized m_modulated, m0_modulated and unmodulated data sets.
Statistical analyses
The seven sets of hippocampal measures were first centred on zero (by dividing the values by the corresponding mean of the whole sample), and then used to perform two kinds of statistical analyses, namely ANOVAs and correlations. First, six ANOVAs with two factors (Hemisphere, Method) of two levels each (Right vs. Left hippocampus; ROI-i vs. ROI-t or Hippeak from m_modulated, m0_modulated or unmodulated data sets) and two groups (Healthy Subjects and aMCI) were performed. In this study, we were more specifically interested in significant Method x Group interactions indicating a significant effect of the method on hippocampal atrophy detection in aMCI. Note that a partial Eta Squared (η 2 p) index was also used to assess each effect size. Post-hoc LSD tests, correcting for multiple comparisons, were applied on significant Method x Group interactions. Furthermore, we used ROC curves to indicate the relationship between sensitivity and specificity for each intergroup discrimination.
We also calculated the AUC, which is an index of overall discriminative ability, for each 9 condition in each hemisphere. Then we calculated the difference between AUCs using a z statistic 22 
Results
The six ANOVAs showed a significant main effect of Group (aMCI < controls; Table   2 ). No significant main effect of Hemisphere or Method was found (see supplementary Table   S .1 for further details). Across ROI-t conditions, there was a significant Group x Method interaction such that voxel-based methods provided lower between-group differences, while no significant interaction was found in the Hip-peak conditions. Compared to Hip-peak conditions, η 2 p values were higher with ROI-t approaches (Figure 1a and 1b; 
Discussion
Our findings first point to the relevance of using modulated, rather than unmodulated, GM data. Thus, unmodulated (i.e. GM density) data provided the most significant Group x Method interaction in the ANOVAs, resulted in the lowest between-group differences in term of percent decreases, were associated to the lowest AUC values and showed the lowest correlation coefficients. Altogether, these results indicate that unmodulated data yield less accurate estimates of hippocampal volume than modulated data.
Second, the lack of significant Group x Method interaction when applying the Hip-peak approach onto any type of VBM-derived data suggests that this approach is as accurate as the ROI-i method in detecting hippocampal atrophy. This is also supported by the similar percent decreases obtained with these methods (nearly 14-18% for Hip-peak versus 18-20% for ROI-i), which are consistent with the values usually reported in the literature (between 11 and 23% depending on criteria for MCI 2,3 ). Thought not significantly different, the percent atrophy was still found to be higher using the ROI-i approach, as previously reported in AD. 10 Secondly, AUC analyses of ROC curves pointed to the higher between-group discrimination accuracy of the Hip-peak method used with modulated data compared to the ROI-t method (especially when used with unmodulated data). Furthermore, we reported no differences between the AUC of the Hip-peak and the ROI-i, methods, suggesting that the Hip-peak approach is as accurate as the gold-standard technique in discriminating aMCI patients from healthy controls.
Consistent with previous studies in AD dementia, 11, 12 our findings thus highlight the validity of VBM for assessing hippocampal atrophy in aMCI, the classical entity that best characterizes the pre-dementia stage of AD. This automatic approach is not only time-saving and operator-independent, but also allows for specifying the exact location of highest changes within the hippocampus. This regional specification may be of interest in detecting specific AD-related atrophic processes, since recent studies have highlighted a differential effect of AD and normal aging on hippocampal volume according to hippocampal subfields and anteriorposterior axis. 18 Conversely, the significant Group x Method interaction in the ROI-i vs. ROI-t comparison for both types of modulated data documents that this approach is less sensitive than the ROI-i in detecting hippocampal atrophy in aMCI. Consistent with this idea, the percent decreases were smaller with the latter (nearly 6-11%) as compared to the former.
Interestingly, the correlation analysis indicates the reverse pattern, i.e. ROI-t values better correlate with ROI-i than Hip-peak values do, which suggests that the ROI-t approach, although slightly less sensitive for the detection of hippocampal atrophy, may offer individual measures of hippocampal volume nearest those provided by the ROI-i approach. The ROI-t method using modulated data should therefore be preferred when individual hippocampal measures are desired, for instance for correlation with memory scores or glucose metabolism. 6, 7 To confirm this interpretation, we assessed the correlations between each hippocampal measures and episodic memory performances obtained in MCI patients using a verbal delayed recognition test. 23 We found that almost all measures significantly correlated to episodic memory performances, but that the ROI-t method using modulated data provided the most similar correlation to that obtained using the ROI-i approach, compared to other VBM-derived methods (See supplementary Figure 3) .
Note that the use of coronal sections defined from the AC-PC line to delineate the hippocampus is a potential limitation of the present study. More precise hippocampal volume measurements could have been obtained if delineating the structure on sections perpendicular to the hippocampal longitudinal axis. 24 Also, further studies would be needed to assess whether the same conclusions apply to other well-delimited brain structures such as the thalamus or caudate nucleus.
In conclusion, our findings highlight the validity of VBM using modulated MRI data for the detection of hippocampal atrophy in group studies of early AD, as well as for extracting individual measures of hippocampal volume for specific purposes such as correlation with independent variables. While ROI-t is the preferred method for the latter, SPM whole-brain analysis was found to be as accurate as the reference ROI-i approach for assessing hippocampal atrophy in early AD, also providing specific locations of greatest atrophy within the hippocampal region. 
ROI-i = individual ROI; ROI-t = ROI template
